Gasparotto, Dino
Zanon, Annarita
Bonaldo, Valerio
Marchiori, Elisa
Casagranda, Massimo
Di Domenico, Erika
Copat, Laura
Asquini, Tommaso Fortunato
Rigoli, Marta
Feltrin, Sirio Vittorio https://orcid.org/0009-0000-8417-8540
Lopez Lorenzo, Nuria
Lolli, Graziano https://orcid.org/0000-0002-8536-5599
Pennuto, Maria https://orcid.org/0000-0001-8634-0767
Requena, Jesùs R
Rota Stabelli, Omar
Minervini, Giovanni
Micheletti, Cristian https://orcid.org/0000-0002-1022-1638
Spagnolli, Giovanni
Faccioli, Pietro https://orcid.org/0000-0002-5546-5054
Biasini, Emiliano https://orcid.org/0000-0002-3927-6341
Funding for this research was provided by:
Fondazione Telethon (GGP20043)
Fondazione Telethon (GMR24T2072)
Ministero dell'Istruzione, dell'Università e della Ricerca (H53D23000860006)
Spanish National Research Agency (AEI) and EU Feder Funds (PID2020-117465GB-I00)
Ministero dell'Istruzione, dell'Università e della Ricerca and Sibylla Biotech (NRRP)
Article History
Received: 6 June 2025
Revised: 25 July 2025
Accepted: 2 September 2025
First Online: 3 October 2025
Disclosure and competing interests statement
: The authors declare the following competing interests: GS, GL, PF, and EB are co-founders and shareholders of Sibylla Biotech SRL ( ). The company exploits the information arising from folding pathway reconstruction for drug discovery in a wide variety of human pathologies.